Smith & Nephew Stock Quote SN. - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1,111.50

Bid

1,108.50

Ask

1,109.00

Volume

1,741,130

1,098.00 Day's Range 1,115.50

887.00 52 Week Range 1,215.50

Market Cap

9.718B

Previous Close

1,102.50

Open

1,100.50

Last Trade

369

1111.5

(O)

Last Trade Time

Financial Volume

19,338,574p

VWAP

1,110.691

Average Volume (3m)

2,561,768

Shares Outstanding

874,320,227

Dividend Yield

PE Ratio

36.85

Earnings Per Share (EPS)

0.3

Revenue

5.55B

Net Profit

263M

Sector

Ortho,prosth,surg Appl,suply

Industry

Ortho,prosth,surg Appl,suply

Website

www.smith-nephew.com

Headquarters

Hertfordshire, Gbr

Founded

1937

Smith & Nephew Plc is listed in the Ortho,prosth,surg Appl,suply sector of the London Stock Exchange with ticker SN.. The last closing price for Smith & Nephew was 1,102.50p. Over the last year, Smith & Nephew shares have traded in a share price range of 887.00p to 1,215.50p.

Smith & Nephew currently has 874,320,227 shares outstanding. The market capitalization of Smith & Nephew is £9.64 billion. Smith & Nephew has a price to earnings ratio (PE ratio) of 36.85.

Best-in-class just got better; Smith+Nephew announces 510(k) clearance of new CATALYSTEM™ Primary Hip System

Best-in-class just got better; Smith+Nephew announces 510(k) clearance of new CATALYSTEM™ Primary Hip System Engineered for precision, confidence and efficiency in surgery - and compatible with...

Smith & Nephew Plc Director/PDMR Shareholding

Smith & Nephew Plc 12 July 2024 SMITH & NEPHEW PLC 12 July 2024 NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF...

Smith+Nephew is trailblazing a new path for female surgeons with its Orthopaedics for All initiative; a first-of-its-kind global advisory board

Smith+Nephew is trailblazing a new path for female surgeons with its Orthopaedics for All initiative; a first-of-its-kind global advisory board Smith+Nephew (LSE:SN, NYSE:SNN), the global medical...

Smith & Nephew Plc Notice of Results

Smith & Nephew Plc 09 July 2024 Timing of Smith+Nephew second quarter trading and first half 2024 results 9 July 2024 Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology...

TOP NEWS: Smith & Nephew jumps as Cevian Capital takes 5% stake

Smith & Nephew PLC got a boost on Thursday, after activist investor Cevian Capital II GP Ltd took a stake in the firm ...

Smith & Nephew Plc TR1: Notification of Major Holdings

Smith & Nephew Plc 04 July 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft...

Smith & Nephew Plc TR1: Notification of Major Holdings

Smith & Nephew Plc 03 July 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft...

Smith & Nephew Plc Total Voting Rights

Smith & Nephew Plc 01 July 2024 1 July 2024 Voting Rights and Capital In conformity with Rule 5.6 of the FCA's Disclosure and Transparency Rules:- The total issued share...

Smith+Nephew takes centre court sponsoring players competing at Wimbledon; global Sports Medicine technology leader helping athletes get back in the game

Smith+Nephew takes centre court sponsoring players competing at Wimbledon; global Sports Medicine technology leader helping athletes get back in the game Smith+Nephew (LSE:SN, NYSE:SNN), the...

Smith+Nephew personalizes robotic-assisted surgery for patients and surgeons with launch of CORIOGRAPH™ Pre-Operative Planning and Modeling Services exclusively for the CORI™ Surgical System

Smith+Nephew personalizes robotic-assisted surgery for patients and surgeons with launch of CORIOGRAPH™ Pre-Operative Planning and Modeling Services exclusively for the CORI™ Surgical System...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	51	4.8090523338	1060.5	1115.5	1054	2248798	1095.91359214	DE
4	125.5	12.7281947262	986	1115.5	961	2312065	1048.64856372	DE
12	111.5	11.15	1000	1115.5	961	2561768	1014.91213129	DE
26	-1	-0.0898876404494	1112.5	1181.5	946	3015386	1032.42754621	DE
52	-91.5	-7.60598503741	1203	1215.5	887	2899592	1033.91146857	DE
156	-436.5	-28.1976744186	1548	1565	887	2739265	1138.35746771	DE
260	-661.5	-37.3096446701	1773	2023	887	2577783	1307.16954168	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUZENuZee Inc	$ 3.82 (270.87%)	122.76M
DRMADermata Therapeutics Inc	$ 2.95 (126.92%)	62.3M
PIRSPieris Pharmaceuticals Inc	$ 13.9199 (74.43%)	5.41M
SLNASelina Hospitality PLC	$ 0.0437 (68.08%)	1.05B
BBLGBone Biologics Corporation	$ 2.05 (64.00%)	39.12M
NXTTNext Technology Holding Inc	$ 2.4399 (-58.08%)	860.51k
NUWENewellis Inc	$ 2.48 (-40.24%)	905.75k
VWEVintage Wine Estates Inc	$ 0.0699 (-37.53%)	29.87M
CONNConns Inc	$ 0.3425 (-32.45%)	3.83M
ATPCAgape ATP Corporation	$ 0.1472 (-31.53%)	6.29M
SLNASelina Hospitality PLC	$ 0.0434 (66.92%)	1.05B
SGMOSangamo Therapeutics Inc	$ 0.5929 (47.74%)	244.23M
NVDANVIDIA Corporation	$ 115.79 (-5.55%)	197.15M
SQQQProShares UltraPro Short QQQ	$ 8.971 (9.67%)	146.69M
TSLATesla Inc	$ 219.324 (-10.98%)	133.63M